Growth Hormone Releasing Hormone in Endothelial Barrier Function.


Journal

Trends in endocrinology and metabolism: TEM
ISSN: 1879-3061
Titre abrégé: Trends Endocrinol Metab
Pays: United States
ID NLM: 9001516

Informations de publication

Date de publication:
06 2021
Historique:
received: 18 02 2021
revised: 25 02 2021
accepted: 01 03 2021
pubmed: 28 3 2021
medline: 1 3 2022
entrez: 27 3 2021
Statut: ppublish

Résumé

Growth hormone releasing hormone (GHRH) is the integral regulator of the growth hormone (GH)-insulin-like growth factor 1 (IGF-1) axis. It exerts mitogenic effects in a plethora of progressive cancers. Recent evidence suggests the emerging role of that 44-amino acid (aa) neuropeptide in lung endothelial barrier function (EBF), which will be discussed herein.

Identifiants

pubmed: 33771415
pii: S1043-2760(21)00047-3
doi: 10.1016/j.tem.2021.03.001
pmc: PMC8102361
mid: NIHMS1692221
pii:
doi:

Substances chimiques

Human Growth Hormone 12629-01-5
Insulin-Like Growth Factor I 67763-96-6
Growth Hormone-Releasing Hormone 9034-39-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

338-340

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103424
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The author declares no conflicts of interest.

Références

Front Med (Lausanne). 2020 Jul 30;7:344
pubmed: 32850879
Neuropeptides. 2004 Feb;38(1):35-9
pubmed: 15003714
Endocrinology. 2019 Jul 1;160(7):1600-1612
pubmed: 31070727
Tissue Barriers. 2019;7(4):1669989
pubmed: 31578921
J Cell Commun Signal. 2021 Mar;15(1):125-129
pubmed: 33185812
Cardiovasc Res. 2010 Jul 15;87(2):243-53
pubmed: 20299335
Lung. 2019 Oct;197(5):541-549
pubmed: 31392398
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
Curr Mol Med. 2016;16(3):299-311
pubmed: 26917260
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):11876-11878
pubmed: 30404912
Curr Res Toxicol. 2020 Jun 10;1:111-115
pubmed: 33094291
EBioMedicine. 2018 Nov;37:557-562
pubmed: 30344124
Biol Rev Camb Philos Soc. 2021 Apr;96(2):541-556
pubmed: 33164297
Endocrinology. 1999 Jul;140(7):3203-9
pubmed: 10385416
Biol Cell. 2019 Jan;111(1):1-17
pubmed: 30302777

Auteurs

Nektarios Barabutis (N)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Electronic address: barabutis@ulm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH